The effect of metabolic inhibitors on the release of vasopressin from the isolated neurohypophysis.
D000654:Amobarbital / Q000494:pharmacology; D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D000968:Antimycin A / Q000494:pharmacology; D002729:Chloromercuribenzoates / Q000494:pharmacology; D003486:Cyanides / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D005978:Glutathione / Q000494:pharmacology; D066298:In Vitro Techniques; D007461:Iodoacetates / Q000494:pharmacology; D010904:Pituitary Gland, Posterior / Q000378:metabolism*; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D014667:Vasopressins / Q000378:metabolism*
D000963:Antimetabolites; D002729:Chloromercuribenzoates; D003486:Cyanides; D004140:Dinitrophenols; D007461:Iodoacetates; D014667:Vasopressins; D000968:Antimycin A; D005978:Glutathione; D000654:Amobarbital; D005033:Ethylmaleimide; D011188:Potassium